Explore

Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Trendline Trendline
Allucent Expands Leadership to Enhance Drug Development for Biopharma

Allucent Expands Leadership to Enhance Drug Development for Biopharma

Allucent Expands Leadership to Enhance Drug Development for Biopharma
Trendline Trendline
Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported

Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported

Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported
Trendline Trendline
Cingulate Inc. Advances ADHD Treatment Amid Regulatory Focus

Cingulate Inc. Advances ADHD Treatment Amid Regulatory Focus

Cingulate Inc. Advances ADHD Treatment Amid Regulatory Focus
Trendline Trendline
Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances
Trendline Trendline
Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial

Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial

Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial
Trendline Trendline
KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments

KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments

KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments
Trendline Trendline
Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions

Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions

Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions
Trendline Trendline
enGene Announces Corporate Name Change to enGene Therapeutics Inc. Reflecting Commercial Transition

enGene Announces Corporate Name Change to enGene Therapeutics Inc. Reflecting Commercial Transition

enGene Announces Corporate Name Change to enGene Therapeutics Inc. Reflecting Commercial Transition
Trendline Trendline
Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights
Trendline Trendline
Takeda Ends Partnership with Denali, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali, Returns Dementia Drug Rights
Trendline Trendline
Amphastar Pharmaceuticals to Present at Needham Healthcare Conference Highlighting Strategic Growth

Amphastar Pharmaceuticals to Present at Needham Healthcare Conference Highlighting Strategic Growth

Amphastar Pharmaceuticals to Present at Needham Healthcare Conference Highlighting Strategic Growth